---
title: "DexCom Executive Chair Kevin Sayer disposes of 26,756 shares worth $2.04 million"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293386066.md"
description: "DexCom Executive Chair Kevin R. Sayer sold 26,756 common shares on July 20, 2026, at a weighted-average price of $76.32 per share, totaling approximately $2.04 million. Following the transaction, his holdings stand at 328,970 shares. The disclosure was filed via EDGAR on July 21, 2026."
datetime: "2026-07-21T20:59:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293386066.md)
  - [en](https://longbridge.com/en/news/293386066.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293386066.md)
---

# DexCom Executive Chair Kevin Sayer disposes of 26,756 shares worth $2.04 million

-   DexCom Executive Chair Kevin R. Sayer sold 26,756 common shares on July 20, 2026. \* Sale priced at USD 76.32 per share on a weighted-average basis. \* Post-transaction holdings totaled 328,970 shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DexCom Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001093557-26-000137), on July 21, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [DXCM.US](https://longbridge.com/en/quote/DXCM.US.md)

## Related News & Research

- [Dexcom Q2 revenue beats estimates raises outlook; raises FY revenue and margin guidance](https://longbridge.com/en/news/294409327.md)
- [DXCM: Q2 2026 saw 13% revenue growth, record new patient starts, and raised guidance for revenue and margins](https://longbridge.com/en/news/294426207.md)
- [DexCom Earnings: What To Look For From DXCM](https://longbridge.com/en/news/294146285.md)
- [BioCardia CEO Peter Altman acquires 5,000 common shares valued at $3,900](https://longbridge.com/en/news/294281889.md)
- [SUI price prediction 2026-2032: Is SUI a good investment?](https://longbridge.com/en/news/293965949.md)